Chiron (XRN) Q4 Core FFO $1.16/sh (+6.4% YoY); FY26 Core FFO guide $4.30-$4.45; switches to monthly dividend

Chiron Real Estate Inc.

2025-FY EPS reported -$0.91 revenue$148,208,000

Q4 GAAP net loss $7.4M ($0.55/sh) vs. prior year net income $1.4M ($0.10/sh).
Q4 Core FFO $1.16/sh, up 6.4% YoY; same-property Cash NOI growth 5.4% YoY.
Full year 2026 Core FFO guidance $4.30-$4.45 per share; no debt maturities in 2026/27.
Dividend switched from quarterly to monthly at $0.25/sh ($3.00 annualized, unchanged); White Rock Medical tenant filed Chapter 11.
Completed $51.3M Series B preferred offering; company renamed from Global Medical REIT to Chiron (XRN).

item 2.02 item 5.03 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Chiron Real Estate Inc.: Changed company name from Global Medical REIT Inc. to Chiron Real Estate Inc (effective 2026-02-23).

Change: charter amendment
Effective: 2026-02-23

Exact text from the filing

On February 19, 2026, the Company filed Articles of Amendment to its charter (the “Amendment”) with the Maryland State Department of Assessments and Taxation and amended and restated its Fourth Amended and Restated Bylaws (as so amended and restated, the “Fifth Amended and Restated Bylaws”), each effective as of 12:01 a.m., Eastern Time, on February 23, 2026, solely to change the Company’s name from Global Medical REIT Inc. to “Chiron Real Estate Inc.”

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

Chiron Real Estate Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-019760

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.